Can Regulators Keep Up with AI’s Rapid Rise in Clinical Trials?
AI Transforming Clinical Trials
The integration of artificial intelligence into clinical trials is revolutionizing drug development, optimizing data analysis, and streamlining patient recruitment. This technological leap offers immense potential for pharmaceutical innovation and efficiency.
Regulatory Challenges Surface
However, as AI’s role expands, concerns mount over whether current regulatory frameworks are equipped to address rapid changes. Issues around data integrity, transparency, and patient safety are fueling debates about the need for updated guidelines and oversight.
